We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fine-Scale Histologic Features Estimated at Low Magnification

By LabMedica International staff writers
Posted on 03 Jul 2018
Print article
Image: The Aperio Scanscope XT whole-slide scanner (Photo courtesy of Leica Microsystems).
Image: The Aperio Scanscope XT whole-slide scanner (Photo courtesy of Leica Microsystems).
Whole-slide imaging has ushered in a new era of technology that has fostered the use of computational image analysis for diagnostic support and has begun to transfer the act of analyzing a slide to computer monitors.

Due to the overwhelming amount of detail available in whole-slide images, analytic procedures, whether computational or visual, often operate at magnifications lower than the magnification at which the image was acquired and as a result, a corresponding reduction in image resolution occurs.

A team of scientists led by those at Drexel University College of Medicine (Philadelphia, PA, USA) examined the correspondence between the color and spatial properties of whole-slide images to elucidate the impact of resolution reduction on the histologic attributes of the slide. They simulated image resolution reduction and modeled its effect on classification of the underlying histologic structure. By harnessing measured histologic features and the intrinsic spatial relationships between histologic structures, they developed a predictive model to estimate the histologic composition of tissue in a manner that exceeds the resolution of the image.

The scientists acquired high-resolution (0.25 µm/pixel) digital images of H&E-stained slides from 88 excised breast specimens at ×40 magnification using the Aperio Scanscope XT whole-slide scanner. For each whole-slide image, they selected two regions of interest (ROIs) for analysis, each 800 µm × 800 µm in size, with an effort made to capture epithelium and stroma. To estimate histologic composition from low-magnification images, they developed a model that uses the color of a pixel to surmise its content. By exploiting the spatial relationships between histologic elements, and measuring their individual color properties, they derived axes in hue-saturation-value (HSV) space that can be used to predict the histologic composition of a pixel.

The team analyzed 79 images acquired at ×40 magnification using whole-slide imaging. Images were stored in a proprietary format that enabled direct access to the image at lower resolutions, thereby reducing bandwidth and facilitating rapid loading for viewing and analysis. The investigators reported that reduction in resolution resulted in a significant loss of the ability to accurately characterize histologic components at magnifications less than ×10, but by utilizing pixel color, this ability was improved at all magnifications.

The authors concluded that multiscale analysis of histologic images requires an adequate understanding of the limitations imposed by image resolution and their findings suggest that some of these limitations may be overcome with computational modeling. The study was published on June 18, 2018, in the journal Archives Of Pathology & Laboratory Medicine.

Related Links:
Drexel University College of Medicine

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Silver Member
ACTH Assay
ACTH ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.